Irbesartan Tablets Market

Global Irbesartan Tablets Market Size, Share And Trend Analysis Report By Type (75 mg Tablets, 150 mg Tablets, and 300 mg Tablets), By Application (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Forecast (2021-2027)

Published: Jan 2022 | Report Code: OMR2025452 | Category : Pharmaceuticals | Delivery Format: /

The global irbesartan tablets market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is anticipated to fuel the market during the forecast period includes an increasing prevalence of high blood pressure globally. Irbesartan is a class of drugs called angiotensin receptor blockers (ARBs). It is taken to treat high blood pressure, to protect the kidney in hypertensive type 2 diabetic patients with laboratory evidence of impaired renal. These tablets function by relaxing blood vessels so that blood can flow more easily. It can be taken with or without food, is available as the brand-name drug Avapro. 

Further, hypertension is a primary contributor to heart disease and stroke, the first and third leading causes of death globally. According to World Health Organization (WHO), an estimated 1.28 billion adults aged 30-79 years globally have hypertension, most (two-thirds) living in low- and middle-income countries. Furthermore, an estimated 46% adults with hypertension are unaware that they have the condition. The high prevalence of hypertension creates a huge public health burden. In the past three decades, the highest global blood pressure levels have moved from high-income countries to low-income countries in South Asia and sub-Saharan Africa due to opposite trends, while blood pressure has been determinedly high in central and eastern Europe which is driving the market growth during the forecast period. Furthermore, FDA’s voluntary recalls owing to suspects of cancer-causing chemicals and contamination are hindering the growth of the global irbesartan tablets market.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: Apotex Inc., Sanofi S.A., and Teva Pharmaceutical Industries Ltd., among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Irbesartan Tablets Market Report Segmentation

By Type 

75 mg Tablets

150 mg Tablets

300 mg Tablets

By Application 

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Irbesartan Tablets Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World